In spite of the many challenges of 2020, Students for Sensible Drug Policy made some incredible accomplishments this year. Through the challenges of the global COVID-19 pandemic, upending of campus life, and rapid shifts in change-making strategies, we’ve seen our network members step up and reinvent the ways we organize. SSDP’s vision of a post-prohibition future where safety, justice, and
This year, Students for Sensible Drug Policy implemented our Psychedelic Pipeline Career Development Program as the first formal pathway for people interested in working in the psychedelic field to connect to professionals in the field with similar values, gain access to unique learning and training opportunities, and ultimately become leaders in the field of psychedelics. The SSDP Psychedelic Pipeline provides
Written by volunteer Sean Lawlor ’19 of Naropa University and the SSDP Psychedelic Pipeline team Over the last year, Students for Sensible Drug Policy has been developing the Psychedelic Pipeline, a network to connect SSDP members and alumni interested in working with psychedelic medicines to quality training, scholarship funds, and career development opportunities, with a deliberate focus on providing access
Daniel Jabbour ‘07, an SSDP all-star alumnus, passed away in April of 2014. To honor and remember him, SSDP created the Daniel Jabbour Scholarship Fund to help send outstanding activists to SSDP conferences. This year, the scholarship committee will be selecting a few SSDPers to attend SSDP2019: The Global Students for Sensible Drug Policy Conference. Daniel’s driving passions in drug
I first found out about Students for Sensible Drug Policy in 2013 when I was only beginning to learn about the harsh realities of the War on Drugs. I decided to donate what I could at the time because I thought the work they were doing was so important and I did not see other student-run organizations that were willing
In high school, I dated someone who I thought was going to be my soulmate for almost 4 years. After watching his life change due to his chaotic relationship with opiates, and knowing I would never be able to help him, I became inspired to go to college and become a therapist specializing in substance use disorders. During and after
Daniel Jabbour ‘07, an SSDP all-star alumnus, passed away in April of 2014. To honor and remember him, SSDP created the Daniel Jabbour Scholarship Fund to help send outstanding activists to SSDP conferences. This year, the scholarship committee will be selecting a few SSDPers to attend SSDP2018: The Students for Sensible Drug Policy Conference and Lobby Day. Daniel’s driving passions
September 20th, 2016 marked the Second Annual 920 Psilocybin Coordinated Day of Action. SSDP is a member of the 920 Coalition which organizes annual events on September 20th focused on the therapeutic potential of psilocybin mushrooms. The 920 coalition also includes other organizations working on promoting awareness about psilocybin mushrooms and other psychedelic substances, such as Psymposia, the Psychedelic Club,
Daniel Jabbour, an SSDP all-star alumnus, passed away in April of this year. To honor and remember him, SSDP created this scholarship fund to send an outstanding activist to the 2014 Students for Sensible Drug Policy Conference and Lobby Day. Daniel’s driving passions in drug policy reform were psychedelics and harm reduction, leading him to found the Psychedelic Society of San Francisco.
This article first appeared at http://the-libertarian.co.uk. Readers are probably familiar with LSD and MDMA (ecstasy), and may have heard of recent research on their medical uses. A lesser-known psychedelic drug, though, also shows potential despite federal prohibition. Ibogaine, extracted from the root bark of the iboga plant, shows great promise in treating drug addiction. Tabernanthe iboga, a tropical shrub, is
This weekend marked the birthday of the inventor of LSD. Albert Hofmann, a Swiss chemist, was known for his discovery of both the chemical synthesis process and psychoactive effects of the well-known psychedelic drug. For his achievements, he was named the top living genius, tied with the inventor of the World Wide Web, by The Telegraph in 2007. He would
From October 11-13 a group of “scientists, artists, activists, seekers and scholars” will come together to learn about and discuss psychedelic drugs in the contexts of science, healing and spirituality. This event is an annual forum that brings people together to learn more about the uses and benefits of psychedelics. Among the distinguished speakers will be
This article originally published on http://the-libertarian.co.uk/ Various countries have seen several deaths in recent months in connection with the illicit drug known as “Ecstasy” or “Molly.” Although these terms originally referred to MDMA, what is commonly sold under these names is increasingly cut with other substances, which are generally cheaper and in some cases dramatically more dangerous. This situation is typical
This article originally published at http://the-libertarian.co.uk/ Readers have presumably all heard of LSD and the drug commonly known as ecstasy, and I have written here previously about their medical uses. There is another substance being investigated for the treatment of some of the same medical issues, however, and it is similarly restricted by a severe prohibition in US federal law. Ayahuasca